Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bradykinin | 6 | 2011 | 157 | 1.270 |
Why?
|
| Trabecular Meshwork | 3 | 2011 | 22 | 0.680 |
Why?
|
| Eye | 2 | 2011 | 89 | 0.650 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2010 | 317 | 0.650 |
Why?
|
| Cyclic AMP | 6 | 2010 | 223 | 0.520 |
Why?
|
| Kinins | 2 | 2011 | 109 | 0.470 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2011 | 150 | 0.450 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2011 | 147 | 0.450 |
Why?
|
| Kallikreins | 2 | 2011 | 323 | 0.440 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2011 | 8 | 0.400 |
Why?
|
| Epoprostenol | 1 | 2010 | 71 | 0.350 |
Why?
|
| Cells, Cultured | 10 | 2011 | 2673 | 0.340 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 110 | 0.340 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 138 | 0.330 |
Why?
|
| Kallikrein-Kinin System | 1 | 2009 | 18 | 0.330 |
Why?
|
| Anterior Chamber | 1 | 2009 | 20 | 0.330 |
Why?
|
| Aqueous Humor | 1 | 2006 | 51 | 0.280 |
Why?
|
| Signal Transduction | 4 | 2011 | 2689 | 0.230 |
Why?
|
| Dinoprostone | 1 | 2003 | 110 | 0.200 |
Why?
|
| Adenylyl Cyclases | 1 | 2001 | 94 | 0.200 |
Why?
|
| Isoenzymes | 1 | 2001 | 308 | 0.180 |
Why?
|
| Bradykinin B2 Receptor Antagonists | 2 | 2011 | 13 | 0.170 |
Why?
|
| Receptor, Bradykinin B2 | 2 | 2011 | 75 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2011 | 160 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 710 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2010 | 2083 | 0.130 |
Why?
|
| Enzyme Activation | 2 | 2011 | 791 | 0.130 |
Why?
|
| RNA, Messenger | 2 | 2010 | 1664 | 0.130 |
Why?
|
| Animals | 8 | 2011 | 20881 | 0.120 |
Why?
|
| Cattle | 2 | 2006 | 475 | 0.120 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2006 | 92 | 0.110 |
Why?
|
| Rats | 5 | 2010 | 5300 | 0.100 |
Why?
|
| Cell Movement | 2 | 2006 | 630 | 0.100 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2011 | 25 | 0.100 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 175 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 42 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 659 | 0.090 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2010 | 73 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 2011 | 270 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2010 | 114 | 0.090 |
Why?
|
| Colforsin | 3 | 2006 | 42 | 0.080 |
Why?
|
| Ciliary Body | 1 | 2009 | 52 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2011 | 1200 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 954 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 682 | 0.070 |
Why?
|
| Anterior Eye Segment | 1 | 2006 | 13 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2006 | 76 | 0.070 |
Why?
|
| Gene Expression | 1 | 2009 | 770 | 0.070 |
Why?
|
| Dipeptides | 1 | 2006 | 89 | 0.070 |
Why?
|
| Isoproterenol | 2 | 2006 | 163 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2006 | 153 | 0.060 |
Why?
|
| Receptors, Angiotensin | 1 | 2004 | 59 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 95 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2004 | 220 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2003 | 626 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2004 | 447 | 0.050 |
Why?
|
| Aprotinin | 1 | 2003 | 55 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2003 | 260 | 0.050 |
Why?
|
| Arginine Vasopressin | 1 | 2001 | 16 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2003 | 122 | 0.050 |
Why?
|
| Humans | 6 | 2011 | 68618 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2003 | 330 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 250 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2001 | 97 | 0.050 |
Why?
|
| Time Factors | 2 | 2006 | 4655 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 455 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 371 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2002 | 483 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1745 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 929 | 0.040 |
Why?
|
| Heart | 1 | 2003 | 850 | 0.040 |
Why?
|
| Inflammation | 1 | 2003 | 1030 | 0.030 |
Why?
|
| Male | 3 | 2010 | 37321 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 2550 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 2006 | 164 | 0.030 |
Why?
|
| Saphenous Vein | 2 | 2006 | 61 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2006 | 765 | 0.030 |
Why?
|
| Middle Aged | 1 | 2011 | 21147 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 2006 | 24 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2006 | 54 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2006 | 61 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 45 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2004 | 10 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2004 | 31 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2004 | 13 | 0.020 |
Why?
|
| Quinazolines | 1 | 2004 | 70 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 317 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2003 | 6 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 901 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2004 | 239 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2002 | 119 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2004 | 211 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2003 | 137 | 0.010 |
Why?
|
| Antibodies | 1 | 2003 | 241 | 0.010 |
Why?
|
| Aorta | 1 | 2002 | 316 | 0.010 |
Why?
|